Literature DB >> 28687465

On the way to find a cure: Purging latent HIV-1 reservoirs.

Christian Schwartz1, Sophie Bouchat2, Céline Marban3, Virginie Gautier4, Carine Van Lint2, Olivier Rohr5, Valentin Le Douce4.   

Abstract

Introduction of cART in 1996 has drastically increased the life expectancy of people living with HIV-1. However, this treatment has not allowed cure as cessation of cART is associated with a rapid viral rebound. The main barrier to the eradication of the virus is related to the persistence of latent HIV reservoirs. Evidence is now accumulating that purging the HIV-1 reservoir might lead to a cure or a remission. The most studied strategy is the so called "shock and kill" therapy. This strategy is based on reactivation of dormant viruses from the latently-infected reservoirs (the shock) followed by the eradication of the reservoirs (the kill). This review focuses mainly on the recent advances made in the "shock and kill" therapy. We believe that a cure or a remission will come from combinatorial approaches i.e. combination of drugs to reactivate the dormant virus from all the reservoirs including the one located in sanctuaries, and combination of strategies boosting the immune system. Alternative strategies based on cell and gene therapy or based in inducing deep latency, which are evoked in this review reinforce the idea that at least a remission is attainable.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-AzadC (Pubmed CID: 451668); BIX 01294 (Pubmed CID: 25150857); Bryostatin (Pubmed CID: 5280757); Chaetocin (Pubmed CID: 11657687); Cure; Ingenol B (Pubmed CID: 44369392); JQ1 (Pubmed CID: 46907787); Latency; Panabinostat (Pubmed CID: 6918837); Prostratin (Pubmed CID: 454217); Remission; Reservoirs; Rituximab (Pubmed CID: 24801580); Romidepsin (Pubmed CID: 5352062); Shock and kill; Valproic acid (Pubmed CID: 3121); Vorinostat (Pubmed CID: 5311)

Mesh:

Substances:

Year:  2017        PMID: 28687465     DOI: 10.1016/j.bcp.2017.07.001

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  31 in total

1.  Scaffold attachment factor B suppresses HIV-1 infection of CD4+ T cells by preventing binding of RNA polymerase II to HIV-1's long terminal repeat.

Authors:  Li Ma; Li Sun; Xia Jin; Si-Dong Xiong; Jian-Hua Wang
Journal:  J Biol Chem       Date:  2018-06-10       Impact factor: 5.157

Review 2.  Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs.

Authors:  Tiffany A Peterson; Andrew G MacLean
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-13       Impact factor: 4.147

3.  Detectability of HIV Residual Viremia despite Therapy Is Highly Associated with Treatment with a Protease Inhibitor-Based Combination Antiretroviral Therapy.

Authors:  Dolores Vaira; Michel Moutschen; Gilles Darcis; Nathalie Maes; Alexander O Pasternak; Anne-Sophie Sauvage; Frédéric Frippiat; Christelle Meuris; Françoise Uurlings; Marianne Lecomte; Philippe Léonard; Majdouline Elmoussaoui; Karine Fombellida
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

4.  Associations of Simian Immunodeficiency Virus (SIV)-Specific Follicular CD8+ T Cells with Other Follicular T Cells Suggest Complex Contributions to SIV Viremia Control.

Authors:  Mohammad Arif Rahman; Katherine M McKinnon; Tatiana S Karpova; David A Ball; David J Venzon; Wenjin Fan; Guobin Kang; Qingsheng Li; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2018-03-05       Impact factor: 5.422

5.  The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation.

Authors:  Xuan-Xuan Zhang; Jian Lin; Tai-Zhen Liang; Heng Duan; Xing-Hua Tan; Bao-Min Xi; Lin Li; Shu-Wen Liu
Journal:  Acta Pharmacol Sin       Date:  2018-05-22       Impact factor: 6.150

6.  Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics.

Authors:  Will Dampier; Neil T Sullivan; Joshua Chang Mell; Vanessa Pirrone; Garth D Ehrlich; Cheng-Han Chung; Alexander G Allen; Mathew DeSimone; Wen Zhong; Katherine Kercher; Shendra Passic; Jean W Williams; Zsofia Szep; Kamel Khalili; Jeffrey M Jacobson; Michael R Nonnemacher; Brian Wigdahl
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-27       Impact factor: 2.205

7.  HIV persists throughout deep tissues with repopulation from multiple anatomical sources.

Authors:  Antoine Chaillon; Sara Gianella; Simon Dellicour; Stephen A Rawlings; Timothy E Schlub; Michelli Faria De Oliveira; Caroline Ignacio; Magali Porrachia; Bram Vrancken; Davey M Smith
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 8.  lncRNAs in T lymphocytes: RNA regulation at the heart of the immune response.

Authors:  Leah M Plasek; Saba Valadkhan
Journal:  Am J Physiol Cell Physiol       Date:  2020-12-09       Impact factor: 4.249

9.  Programmed death ligand-1 induction restrains the cytotoxic T lymphocyte response against microglia.

Authors:  Priyanka Chauhan; Shuxian Hu; Sujata Prasad; Wen S Sheng; James R Lokensgard
Journal:  Glia       Date:  2020-10-31       Impact factor: 7.452

Review 10.  Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?

Authors:  Thanarat Salahong; Christian Schwartz; Rungroch Sungthong
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.